# Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions

> **NCT01005771** · PHASE2 · COMPLETED · sponsor: **Ferrer Internacional S.A.** · enrollment: 200 (actual)

## Conditions studied

- Secondarily Infected Traumatic Lesions

## Interventions

- **DRUG:** GF-001001-00
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01005771
- **Lead sponsor:** Ferrer Internacional S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2010-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005771, "Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01005771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*